© 2022 Biopharma

A mid-size biopharma with A cell therapy platform, considered using its technology
for vaccination. BIM was approached to guide in the R&D and business consideration of
choosing the best antigens.

After an initial analysis of the platform, BIM generated an overall work plan to
implement the R&D strategy. In parallel, our team assist the R&D team in conducting and
managing the R&D plan, until all POC milestones were achieved.

Made on